Anodal tDCS Clinical Trial
Verified date | June 2013 |
Source | Hasselt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Belgium: Ethics Committee |
Study type | Interventional |
The current study investigates the effects of tDCS in patients with multiple sclerosis (MS). The investigators hypothesize that anodal tDCS will increase motor performance in patients with MS.
Status | Completed |
Enrollment | 31 |
Est. completion date | October 2012 |
Est. primary completion date | October 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - at least 18 years old - male and female Exclusion Criteria: - relapse in the last 3 months - when not suitable for tDCS (screening) - if TMS measures can not be completed |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hasselt University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motor performance on a unimanual sequence learning task | Patients were instructed to perform a unimanual sequence-learning task consisting of sequential finger presses. The following parameters were measured: Correct sequences/mean inter tap interval (ITI), percentage correct key presses/mean ITI, percentage correct sequences, percentage correct key presses, mean ITI, and mean correct sequences in the performance interval. | Baseline, during training and POST (30 min after baseline) intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03144102 -
Combining tDCS With VR-based Motor Training in Stroke
|
N/A |